BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2968078)

  • 1. Contraception and the skin.
    Kovacs G; Marks R
    Australas J Dermatol; 1987 Aug; 28(2):86-92. PubMed ID: 2968078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of oral contraceptives from a dermatological viewpoint].
    Marghescu S
    Ther Ggw; 1979 Aug; 118(8):1230-43. PubMed ID: 158843
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gynecologic side effects of oral contraceptives].
    Hirvonen E
    Duodecim; 1973 Oct; 89(24):1618-25. PubMed ID: 4272449
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral contraceptives and the skin.
    Jelinek JE
    Am Fam Physician; 1971 Nov; 4(5):68-74. PubMed ID: 4330118
    [No Abstract]   [Full Text] [Related]  

  • 5. [Principles of hormonal contraception].
    Hammerstein J
    Arch Dermatol Forsch; 1972; 244():478-90. PubMed ID: 4119339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous side effects of oral contraceptives.
    Jelinek JE
    Arch Dermatol; 1970 Feb; 101(2):181-6. PubMed ID: 4244175
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal contraception and dermatology].
    Prenen M; Ledoux-Corbusier M
    Arch Belg Dermatol Syphiligr; 1971; 27(3):253-8. PubMed ID: 4261461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
    Henrion R; Laveissiere MN
    Contracept Fertil Sex (Paris); 1982 Oct; 10(10):653-7. PubMed ID: 12338447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous complications of estro-progestative agents: statistical study. Apropos of 562 users].
    Dugois P; Amblard P; Manent J; Deshors G
    Ann Dermatol Syphiligr (Paris); 1971; 98(5):479-86. PubMed ID: 4259026
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: A survey-based study.
    Lullo JJ; Ethington E; Arshanapalli A; Reserva J; Jiang A; Adams W; Graziano S; Tung R
    J Am Acad Dermatol; 2018 Aug; 79(2):364-365. PubMed ID: 29288103
    [No Abstract]   [Full Text] [Related]  

  • 13. The side effects of oral contraceptives.
    Godfrey S; Vallings R
    N Z Med J; 1969 Jan; 69(440):14-9. PubMed ID: 4237353
    [No Abstract]   [Full Text] [Related]  

  • 14. Selecting the optimum oral contraceptive.
    Nelson JH
    J Reprod Med; 1973 Oct; 11(4):135-41. PubMed ID: 4270294
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous complications in immunosuppressed renal homograft recipients.
    Koranda FC; Dehmel EM; Kahn G; Penn I
    JAMA; 1974 Jul; 229(4):419-24. PubMed ID: 4275980
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of oral contraceptives on male-pattern alopecia, seborrhoea, acne vulgaris and hirsutism. Anamnestic study on 325 women].
    Hoffmann E; Meiers HG; Hubbes A
    Dtsch Med Wochenschr; 1974 Oct; 99(43):2151-4, 2157. PubMed ID: 4139008
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hair-growth disorders in relation to pregnancy and hormonal contraception].
    Zaun H
    Z Geburtshilfe Perinatol; 1973 Apr; 177(2):67-73. PubMed ID: 4578114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dermatological complications caused by oral contraceptives].
    Deharo C; Berbis P; Privat Y
    Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermal changes in response to hormonal contraceptives (author's transl)].
    Scholz C; Donat H
    Zentralbl Gynakol; 1981; 103(19):1158-64. PubMed ID: 6458978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [To which women should antiandrogen-effective ovulation inhibitors be prescribed? (hirsutism, seborrhea, alopecia)].
    Strecker JR
    Hippokrates; 1978 May; 49(2):200-1. PubMed ID: 148441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.